22157.jpg
The Rise of Pulsed Field Ablation: A Safer, Minimally Invasive Solution for Atrial Fibrillation and Cardiac Arrhythmias
October 18, 2023 06:28 ET | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
October 04, 2023 08:49 ET | Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Electrophysiology Ablation Market Grows Strong, Aiming for US$ 7.9 Billion by 2033 | Persistence Market Research
September 28, 2023 06:03 ET | Persistence Market Research
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The electrophysiological ablation market is expected to generate US$ 3.1 billion in revenue globally in 2022 and grow at a CAGR of 8.8% to US$ 7.9...
Stereotaxis Logo - New Tagline - Black Text.png
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
September 06, 2023 08:56 ET | Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
biosig_rgb.png
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023 10:30 ET | BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
August 23, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Emergen logo.png
Global Electrophysiology Market Size to Reach USD 18.01 Billion 2032 | Emergen Research
August 22, 2023 10:00 ET | Emergen Research
Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Anticipated to demonstrate a stable journey, the global electrophysiology market is poised to attain a value of USD 18.01 Billion, fostering a consistent...
biosig_rgb.png
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
August 22, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET | BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...